Literature DB >> 14999217

Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction.

A Guay1, R Munarriz, J Jacobson, L Talakoub, A Traish, F Quirk, I Goldstein, R Spark.   

Abstract

Androgen insufficiency is a recognized cause of sexual dysfunction in men and women. Age-related decrements in adrenal and gonadal androgen levels also occur naturally in both sexes. At present, it is unclear if a woman's low serum androgen level is a reflection of the expected normal age-related decline or indicative of an underlying androgen-deficient state. We studied premenopausal women with no complaints of sexual dysfunction to help define a normal female androgen profile. In all, 60 healthy, normally menstruating women, ages 20-49 y, were studied. The Abbreviated Sexual Function Questionnaire was administered along with a detailed interview. Radioimmunoassay measurements of morning serum testosterone (T), free testosterone (fT), dehydroepiandrosterone-sulfate (DHEAS), sex hormone-binding globulin (SHBG), and free androgen index (FAI) were measured during days 8-15 of the menstrual cycle. In women 20-49 y old without complaints of sexual dysfunction, serum androgen levels exhibit a progressive stepwise decline. Comparing values obtained in women age 20-29 y to those obtained in women 40-49 y, specific hormone decrements were DHEAS 195.6-140.4 microg/dl, serum T 51.5-33.7 ng/dl, fT 1.51-1.03 pg/ml. SHBG did not change significantly in women in this age group. The FAI reflected the age-related decrease in female androgen levels. The framework for the development of a female androgen profile in women with no complaints of sexual dysfunction has been established, and an age-related decrease in testosterone and its adrenal precursor, DHEAS, has been demonstrated. The FAI mirrors these decreases and its usefulness in clinical practice is confirmed. A precipitous decline in all androgens occurs after the decade of the 20s, yet SHBG does not show a significant change throughout the premenopausal years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999217     DOI: 10.1038/sj.ijir.3901178

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  9 in total

1.  StuI polymorphism on the androgen receptor gene is associated with recurrent spontaneous abortion.

Authors:  Tahere Jahaninejad; Nasrin Ghasemi; Seyyed Mehdi Kalantar; Mohammad Hasan Sheikhha; Hossein Pashaiefar
Journal:  J Assist Reprod Genet       Date:  2013-02-22       Impact factor: 3.412

2.  Opioid analgesics suppress male gonadal function but opioid use in males and females does not correlate with symptoms of sexual dysfunction.

Authors:  Dana Wong; Dan P Gray; Mark Simmonds; Saifee Rashiq; Igor Sobolev; Donald W Morrish
Journal:  Pain Res Manag       Date:  2011 Sep-Oct       Impact factor: 3.037

3.  Vitamin E as alternative local treatment in genitourinary syndrome of menopause: a randomized controlled trial.

Authors:  Nahid Golmakani; Aazam Parnan Emamverdikhan; Ahmadreza Zarifian; Sayyed Abolghasem Sajadi Tabassi; Malihe Hassanzadeh
Journal:  Int Urogynecol J       Date:  2018-07-03       Impact factor: 2.894

4.  An evaluation of the effect of infertility on marital, sexual satisfaction indices and health-related quality of life in women.

Authors:  Sameer Valsangkar; Trupti Bodhare; Samir Bele; Surendranath Sai
Journal:  J Hum Reprod Sci       Date:  2011-05

Review 5.  Benefits and risks of testosterone treatment for hypoactive sexual desire disorder in women: a critical review of studies published in the decades preceding and succeeding the advent of phosphodiesterase type 5 inhibitors.

Authors:  Sandra Léa Bonfim Reis; Carmita H N Abdo
Journal:  Clinics (Sao Paulo)       Date:  2014       Impact factor: 2.365

Review 6.  Genetics of recurrent pregnancy loss among Iranian population.

Authors:  Meysam Moghbeli
Journal:  Mol Genet Genomic Med       Date:  2019-07-30       Impact factor: 2.183

7.  International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.

Authors:  Sharon J Parish; James A Simon; Susan R Davis; Annamaria Giraldi; Irwin Goldstein; Sue W Goldstein; Noel N Kim; Sheryl A Kingsberg; Abraham Morgentaler; Rossella E Nappi; Kwangsung Park; Cynthia A Stuenkel; Abdulmaged M Traish; Linda Vignozzi
Journal:  J Womens Health (Larchmt)       Date:  2021-04-01       Impact factor: 2.681

8.  Do oral combined contraceptive pills modify body image and sexual function?

Authors:  Krzysztof Nowosielski
Journal:  Reprod Biol Endocrinol       Date:  2022-06-28       Impact factor: 4.982

9.  Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.

Authors:  Oliver D Howes; Michael J Wheeler; Lyn S Pilowsky; Sabine Landau; Robin M Murray; Shubulade Smith
Journal:  J Clin Psychiatry       Date:  2007-03       Impact factor: 4.384

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.